About: Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.83 (+0.34%)
BNTC NASDAQ Benitec Biopharma Inc.
Benitec Biopharma Inc. share price
Atividade de preço de BNTC
Último preço
$ 8,830
Variação (24h)
0,03 USD (0,34%)
Volume
162.34K
Volume (média 4 sem.)
-
Abertura
$ 8,73
Variação do dia
$ 8,73 - $ 9,11
Fechamento anterior
$ 8,80
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
BNTC price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals